Hypertension Remission after Colorectal Cancer Surgery: A Single-Center Retrospective Study

Yu-Xi Cheng1, Wei Tao1, Xiao-Yu Liu1

  • 1Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Nutrition and Cancer
|January 7, 2022
PubMed

Insights

Colorectal cancer surgery led to hypertension remission in 20.7% of patients. Age was a predictive factor, but the type of surgery was not, for hypertension remission after colorectal cancer surgery.

Area of Science:

  • Oncology
  • Cardiology
  • Surgical Oncology

Background:

  • Colorectal cancer (CRC) is a significant global health concern.
  • Hypertension is a common comorbidity in cancer patients.
  • The impact of CRC surgery on pre-existing hypertension requires further investigation.

Purpose of the Study:

  • To evaluate the effect of colorectal cancer surgery on hypertension remission.
  • To identify factors influencing hypertension remission post-colorectal cancer surgery.

Main Methods:

  • Retrospective enrollment of patients who underwent colorectal cancer surgery.
  • Recording of hypertension status before and 1 year after surgery.
  • Statistical analysis to determine remission rates and predictive factors.

Main Results:

  • A total of 387 patients were analyzed.
  • Hypertension remission was observed in 80 patients, yielding a remission rate of 20.7%.
  • Age was identified as a significant predictive factor for hypertension remission; surgical type was not.

Conclusions:

  • Colorectal cancer surgery results in a 20.7% hypertension remission rate 1 year post-operatively.
  • Patient age is a key factor in predicting hypertension remission following colorectal cancer surgery.
  • Further research may explore mechanisms linking CRC surgery and cardiovascular outcomes.

Related Concept Videos